norm: dogwood therapeuticsNAICS Pharmaceutical Preparations · USno LEI · CIK 0001818844Max severity: Low

Canonical registry

Dogwood Therapeutics, Inc.

ent_019fa1eb2fd6fc1d58cd2e0ae0fc27c9

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Dogwood Therapeutics, Inc.
Normalized: dogwood therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001818844
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-03-18
Item 1C of Form 10-K states the Company has not experienced any cybersecurity attacks as of the filing date. The Company maintains a cybersecurity risk management program, including intrusion detection, access controls, and employee training against social engineering/phishing. No material impact on business strategy, operations, or financial condition is reported.